voclosporin FDA approval date

The FDA approved voclosporin on 22 Jan 2021.

FDA approval date
22 Jan 2021

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisNCT05962788AUPHPhase 3Terminated2025-07-04Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-01-22DayvoclosporinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213716", "applicant_as_listed_by_fda": "AURINIA", "brand_names": ["LUPKYNIS"], "active_ingredients": ["VOCLOSPORIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210122", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026